Application Detail
Status
OpenDescription of Medical Service
ImmunoHistoChemistry test for evaluation of Programmed Cell Death-Ligand 1 (PD-L1) expression to determine eligibility for treatment with pembrolizumabDescription of Medical Condition
Locally advanced/unresectable or metastatic urinary bladder cancerReason for Application
New MBS itemMedical Service Type
InvestigativePrevious Application Number
Not ApplicableAssociated Documentation
Application Form
-PICO Confirmation
Consultation Protocol (PDF 1132 KB)Consultation Protocol (Word 706 KB)